Revance Therapeutics RVNC
$ 3.86
1.45%
Quarterly report 2024-Q3
added 11-07-2024
Revance Therapeutics EV/EBITDA Ratio 2011-2024 | RVNC
Annual EV/EBITDA Ratio Revance Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-4.83 | -5.24 | -4.95 | -4.01 | -6.41 | -6.13 | -4.31 | -2.88 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-2.88 | -6.41 | -4.84 |